Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

30 April 1999

Effects of baclophen on the growth of 16/C transplantable mouse mammary adenocarcinoma (in vivo)

Maria Mazurkiewicz, Joanna Wietrzyk, Adam Opolski, Czesław Radzikowski, Zdzisław Kleinrok

Med Sci Monit 1999; 5(3): BR434-439 :: ID: 504762

Abstract

Described here is the protective effect of GABA receptor agonists (baclophen and muscimol) on the development of chemically induced digestive tract rodent tumors. The aim of this study was to evaluate the antitumor effect of baclophen administration on the growth of a transplantable mouse mammary cancer 16/C. All mice (C3H/W) were inoculated subcutaneously with 16/C tumor cells into the right flank region. Experimental group mice received baclophen in different doses (10mg/kg/day and 20mg/kg/day) and two different schedules. Control mice received a 0.9% NaCl solution only. Observations were carried out for a period of 22 days and tumor measurements were performed. The tumor volume was calculated by means of the formula (a2 x b)/2. Statistical analysis was performed by means of the t-Student's test. The difference was considered as significant when the p value was less than 0.05. We demonstrated an inhibitory effect of baclophen administration on the growth of transplantable mouse mammary cancer. This effect was dependent both on the dose and schedule of baclophen administration. Twenty mg/kg/day beginning 6 days before tumor implantation and ending on the 19th dayappeared to be the most effective treatment schedule. The mechanism of baclophen's antitumor effect remains unclear. We may consider baclophen's known effect on the hormonal system. It is also known that GABA and its agonists may influence some stages of neuroendocrine regulation. Moreover, there exists strong evidence that the GABA-ergic system is regulated by hormones. It is known that the mammary gland is affected by hormones, and breast cancer is classified as a hormone-dependent tumor.

Keywords: GAD, GABA, Baclophen, treatment

Add Comment 0 Comments

Editorial

01 June 2024 : Editorial  

Editorial: Concerns as Highly Pathogenic Avian Influenza (HPAI) Virus of the H5N1 Subtype is Identified in Dairy Cows and Other Mammals

Dinah V. Parums

DOI: 10.12659/MSM.945315

Med Sci Monit 2024; 30:e945315

0:00

In Press

Review article  

Impact of Workplace Bullying on Nursing Care Quality: A Comprehensive Review

Med Sci Monit In Press; DOI: 10.12659/MSM.944815  

Clinical Research  

Anterior Plate-Supported Cannulated Screw Surgery for Ankle Arthrodesis: Clinical and Radiologic Results in...

Med Sci Monit In Press; DOI: 10.12659/MSM.944452  

Clinical Research  

Elevated Plasma Levels of Growth Arrest Specific 6 (Gas6) Protein in Severe Obesity: Implications for Adipo...

Med Sci Monit In Press; DOI: 10.12659/MSM.944462  

Database Analysis  

Systemic Immune-Inflammation Index (SII) as a Predictor of Short-Term Mortality Risk in Sepsis-Associated A...

Med Sci Monit In Press; DOI: 10.12659/MSM.943414  

Most Viewed Current Articles

17 Jan 2024 : Review article   2,048,648

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research   1,553,068

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research   690,454

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial   50,367

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750